Overview

Riociguat for Sarcoidosis Associated Pulmonary Hypertension

Status:
Unknown status
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
Double blind placebo controlled trial of riociguat for sarcoidosis associated pulmonary hypertension
Phase:
Phase 4
Details
Lead Sponsor:
University of Cincinnati
Treatments:
Riociguat